100,000 Genomes Project
The service will offer whole-genome sequencing to English patients with rare diseases and cancer as part of routine care.
High Genetic Diversity Found Among Nilo-Saharan Speakers in New Study
The study, which sequenced the genomes of 50 Nilo-Saharan speakers, also uncovered signs of selective sweeps that could represent environmental adaptations.
Illumina, UK Agencies Partner on £28M Sequencing Study of COVID-19 Patients
Illumina will sequence 35,000 whole genomes for the Genetics of Mortality in Critical Care (GenOMICC) study and will provide an in-kind contribution.
Biocartis, Immunexpress Ink Co-Commercialization Agreement for Sepsis Test
Biocartis will lead commercialization in Europe as the exclusive distributor of the SeptiCyte Rapid test, while Immunexpress will lead commercialization of the test in the US.
Illumina, Genomics England Ink Deal to Sequence up to 300K People
The deal provides whole-genome sequencing for patients with rare diseases or cancer and could make sequencing part of the standard of care for NHS England.